Intermittent and absolute claudication distances · people with critical limb ischaemia due to non‐reconstructable peripheral arterial disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Change in absolute walking distance from baseline (m) · people with intermittent claudication
1 finding from 1 review
Intervention not reported
Change in claudication distance from baseline (m) · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Amputation‐free survival · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Revascularisation‐free survival · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Major adverse cardiovascular events (MACE) · people with intermittent claudication
The intervention showed no clear difference in major adverse cardiovascular events (MACE) (low certainty).
1 finding from 1 review
Intervention not reported
Major adverse limb events (MALE) · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Above‐ankle amputation · people with intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in claudication distance from baseline (m) · intermittent claudication
1 finding from 1 review
Absolute claudication distance (change in metres) · intermittent claudication
1 finding from 1 review
Arterial revascularisation · intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Amputation · intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse event related to study medication ‐ headache (number of cases) · intermittent claudication
Cilostazol may leads to higher adverse event related to study medication ‐ headache (number of cases) compared with pentoxifylline (low certainty).
1 finding from 1 review
Cardiovascular events · intermittent claudication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life (change in points, SF‐36, WIQ) · intermittent claudication
1 finding from 1 review
Absolute claudication distance (change in metres) · intermittent claudication
1 finding from 1 review
Arterial revascularisation · intermittent claudication
It is very uncertain whether cilostazol changes arterial revascularisation (number of cases) compared with placebo (very low certainty).
1 finding from 1 review
Amputation · intermittent claudication
It is very uncertain whether cilostazol changes amputation (number of cases) compared with placebo (very low certainty).
1 finding from 1 review
Adverse event related to study medication ‐ headache (number of cases) · intermittent claudication
Cilostazol probably leads to higher adverse event related to study medication ‐ headache (number of cases) compared with placebo (moderate certainty).
1 finding from 1 review
Cardiovascular events · intermittent claudication
Cilostazol showed no clear difference in cardiovascular event (number of cases) compared with placebo (low certainty).
1 finding from 1 review